Literature DB >> 1447648

Cryptococcal osteomyelitis and cellular immunodeficiency associated with interleukin-2 deficiency.

R U Sorensen1, K D Boehm, D Kaplan, M Berger.   

Abstract

We describe an unusual example of cellular immunodeficiency associated with interleukin-2 deficiency in an otherwise healthy 15-year-old boy who had isolated cryptococcal osteomyelitis of the scapula at 10 years of age. His previous medical history was remarkable only for prolonged, severe varicella infection at 6 years of age. He had persistent moderate lymphopenia, anergy, and absent lymphocyte blastogenic responses to mitogens, antigens, or monoclonal T cell antibodies. Subnormal blastogenic responses were seen after exposure to high concentrations of phorbol esters. Immunoglobulin levels and specific antibodies were normal. The patient has been in good health since treatment of his osteomyelitis. However, his lymphocyte blastogenic responses to mitogens have remained absent during 4 years of observation; investigation of the cause revealed a specific interleukin-2 deficiency resulting from defective generation of interleukin-2 messenger ribonucleic acid. Secretion of interleukin-1 by monocytes was normal, suggesting that the abnormal blastogenic response and interleukin-2 production were due to a problem intrinsic to T lymphocytes. The generation of messenger ribonucleic acid for interleukin-4 was not affected. Interferon-gamma was produced at subnormal levels. The addition of recombinant interleukin-2 restored lymphocyte blastogenic responses and increased the expression of interleukin-2 receptors. The clinical findings and immunologic abnormalities present in this patient differ from other primary and secondary immunodeficiencies associated with interleukin-2 deficiency. Thus our observations in this patient extend the spectrum of immunodeficiencies associated with abnormalities in the production of this important cytokine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447648     DOI: 10.1016/s0022-3476(05)80331-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Therapy of Cryptococcal Meningitis in non-HIV-infected Patients.

Authors:  Peter G. Pappas
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

2.  Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemia.

Authors:  Djin-Ye Oh; P Pallavi Madhusoodhan; Deborah J Springer; Kenneth Inglima; Ali A Chaudhri; Joseph Heitman; Elizabeth A Raetz; Alka Khaitan; Mona Rigaud
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

3.  Skeletal cryptococcosis: Case report and review of the literature.

Authors:  L Wood; L Miedzinski
Journal:  Can J Infect Dis       Date:  1996-03

4.  [Bacterial osteitis. Special considerations in immunocompromised patients].

Authors:  C Niedhart; O Miltner; K-W Zilkens; F U Niethard
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

5.  First Description of Oral Cryptococcus neoformans Causing Osteomyelitis of the Mandible, Manubrium and Third Rib with Associated Soft Tissue Abscesses in an Immunocompetent Host.

Authors:  Andrew R DiNardo; Davin Schmidt; Angela Mitchell; Yoav Kaufman; David J Tweardy
Journal:  Clin Microbiol Case Rep       Date:  2015

6.  Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.

Authors:  Jiraprapa Wipasa; Panuwat Wongkulab; Kriangkrai Chawansuntati; Romanee Chaiwarit; Khuanchai Supparatpinyo
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 7.  Skeletal cryptococcosis from 1977 to 2013.

Authors:  Heng-Xing Zhou; Lu Lu; Tianci Chu; Tianyi Wang; Daigui Cao; Fuyuan Li; Guangzhi Ning; Shiqing Feng
Journal:  Front Microbiol       Date:  2015-01-14       Impact factor: 5.640

8.  Gastrointestinal cryptococcosis presenting as spontaneous jejunal perforation in a nonimmunocompromised host.

Authors:  Mark Chaitowitz; Marie-Leen Shaw; Taole R Mokoena
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.